The drugmaker says it expects to deliver a total of 100 million doses to the U.S. by the end of March, another 100 million by the end of May, and another 100 million by the end of July. It originally planned to deliver all of the 300 million doses ordered by the U.S. by the end of September.
So far, Moderna has supplied the U.S. with 45.4 million vaccine doses, and 25.2 million have been administered, according to CDC data.
Moderna said short-term delays in the final stages of production at its fill-and-finish contractor, Catalent, recently delayed the release of some vaccine doses, but the delays are expected to be resolved soon and shouldn’t affect monthly delivery targets.
Read the full news release here.
More articles on pharmacy:
Bristol Myers Squibb, Sanofi ordered to pay $834M for improper drug marketing
Multiple federal vaccine distribution programs causing confusion for states, governors say
Pfizer COVID-19 vaccine cuts symptomatic cases by 94%, data shows
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
